You are here: Home » PTI Stories » National » News
Business Standard

Aussie schoolboys recreate price-gouged HIV medicine

AFP  |  Sydney 

A group of Australian schoolchildren working on a shoestring budget have recreated the HIV drug whose price was controversially jacked up 5,000 per cent by a former hedge fund manager.

US drug company chief Martin Shkreli became a global figure of hate after buying the rights to Daraprim and then raising the price in the United States from USD 13.50 a tablet to USD 750.



Youngsters at a Sydney school decided to draw attention to the scandal and went to work creating pyrimethamine, the active ingredient for Daraprim, an anti-parasitic used to treat people with low immune systems such as those with HIV, chemotherapy patients and pregnant women.

Student James Wood said he and his friends had started off with just USD 20 of the drug, and in one reaction had produced thousands of dollars' worth.

"So we really just hope this makes a point about the nature of the pharmaceutical industry," he told the Sydney Morning Herald.

University of Sydney research chemist Alice Williamson helped the boys synthesise the medicine using an online platform Open Source Malaria.

The pupils "shared the outrage of the general public," Williamson said.

"The original recipe, if you like, to make this molecule was from a patent that was referenced on Wikipedia," she said.

Turing Pharmaceuticals continue to sell the only FDA-approved form of the drug in the US, but reportedly cut the price in half for hospitals after the outcry.

Daraprim, which figures on the World Health Organisation list of essential medicines, is cheap in most countries, with 50 tablets selling in Australia for USD 10.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Aussie schoolboys recreate price-gouged HIV medicine

A group of Australian schoolchildren working on a shoestring budget have recreated the HIV drug whose price was controversially jacked up 5,000 per cent by a former hedge fund manager. US drug company chief Martin Shkreli became a global figure of hate after buying the rights to Daraprim and then raising the price in the United States from USD 13.50 a tablet to USD 750. Youngsters at a Sydney school decided to draw attention to the scandal and went to work creating pyrimethamine, the active ingredient for Daraprim, an anti-parasitic used to treat people with low immune systems such as those with HIV, chemotherapy patients and pregnant women. Student James Wood said he and his friends had started off with just USD 20 of the drug, and in one reaction had produced thousands of dollars' worth. "So we really just hope this makes a point about the nature of the pharmaceutical industry," he told the Sydney Morning Herald. University of Sydney research chemist Alice Williamson helped the ... A group of Australian schoolchildren working on a shoestring budget have recreated the HIV drug whose price was controversially jacked up 5,000 per cent by a former hedge fund manager.

US drug company chief Martin Shkreli became a global figure of hate after buying the rights to Daraprim and then raising the price in the United States from USD 13.50 a tablet to USD 750.

Youngsters at a Sydney school decided to draw attention to the scandal and went to work creating pyrimethamine, the active ingredient for Daraprim, an anti-parasitic used to treat people with low immune systems such as those with HIV, chemotherapy patients and pregnant women.

Student James Wood said he and his friends had started off with just USD 20 of the drug, and in one reaction had produced thousands of dollars' worth.

"So we really just hope this makes a point about the nature of the pharmaceutical industry," he told the Sydney Morning Herald.

University of Sydney research chemist Alice Williamson helped the boys synthesise the medicine using an online platform Open Source Malaria.

The pupils "shared the outrage of the general public," Williamson said.

"The original recipe, if you like, to make this molecule was from a patent that was referenced on Wikipedia," she said.

Turing Pharmaceuticals continue to sell the only FDA-approved form of the drug in the US, but reportedly cut the price in half for hospitals after the outcry.

Daraprim, which figures on the World Health Organisation list of essential medicines, is cheap in most countries, with 50 tablets selling in Australia for USD 10.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Aussie schoolboys recreate price-gouged HIV medicine

A group of Australian schoolchildren working on a shoestring budget have recreated the HIV drug whose price was controversially jacked up 5,000 per cent by a former hedge fund manager.

US drug company chief Martin Shkreli became a global figure of hate after buying the rights to Daraprim and then raising the price in the United States from USD 13.50 a tablet to USD 750.

Youngsters at a Sydney school decided to draw attention to the scandal and went to work creating pyrimethamine, the active ingredient for Daraprim, an anti-parasitic used to treat people with low immune systems such as those with HIV, chemotherapy patients and pregnant women.

Student James Wood said he and his friends had started off with just USD 20 of the drug, and in one reaction had produced thousands of dollars' worth.

"So we really just hope this makes a point about the nature of the pharmaceutical industry," he told the Sydney Morning Herald.

University of Sydney research chemist Alice Williamson helped the boys synthesise the medicine using an online platform Open Source Malaria.

The pupils "shared the outrage of the general public," Williamson said.

"The original recipe, if you like, to make this molecule was from a patent that was referenced on Wikipedia," she said.

Turing Pharmaceuticals continue to sell the only FDA-approved form of the drug in the US, but reportedly cut the price in half for hospitals after the outcry.

Daraprim, which figures on the World Health Organisation list of essential medicines, is cheap in most countries, with 50 tablets selling in Australia for USD 10.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard